1. Identification of CD56 dim subpopulation marked with high expression of GZMB/PRF1/PI‐9 in CD56 + interferon‐α‐induced dendritic cells
- Author
-
Misa Togi, Terutsugu Koya, Takuya Sakamoto, Asuka Watanabe, Kuniyoshi Iwabuchi, Shigetaka Shimodaira, Tomohisa Kato, and Makoto Taniguchi
- Subjects
0303 health sciences ,medicine.medical_treatment ,hemic and immune systems ,chemical and pharmacologic phenomena ,Cell Biology ,Immunotherapy ,Biology ,Serpin ,Acquired immune system ,In vitro ,GZMB ,Cell biology ,Granzyme B ,03 medical and health sciences ,Perforin ,Genetics ,medicine ,biology.protein ,Cytotoxic T cell ,030304 developmental biology - Abstract
As the sentinels of innate and adaptive immune system, dendritic cells (DCs) have been considered to hold a great promise for medical application. Among the diverse types of DCs, monocyte-derived DCs (mo-DCs) generated in vitro have been most commonly employed. We have been improving the culture protocol and devised a protocol to produce mature interferon-α-induced DCs (IFN-DCs), hereinafter called (mat)IFN-DCs. While exploring the relationship between the expression of CD56 and the cytotoxic activity of (mat)IFN-DCs, we unexpectedly found that sorting of (mat)IFN-DCs with CD56 antibody-coated microbeads (MB) resulted in fractionating cells with tumoricidal activity into the flow-through (FT) but not MB-bound fraction. We uncovered that the FT fraction contains cells expressing low but substantial level of CD56. Moreover, those cells express granzyme B (GrB), perforin (PFN), and serpin B9 at high levels. By employing a specific inhibitor of PFN, we confirmed that direct tumoricidal activity relies on the GrB/PFN pathway. We designated subpopulation in FT fraction as CD56dim and that in CD56 positively sorted fraction as CD56bright , respectively. This is the first time, to our knowledge, to identify subpopulations of CD56-positive IFN-DCs with distinct tumoricidal activity which is ascribed to high expression of the components of GrB/PFN pathway.
- Published
- 2021
- Full Text
- View/download PDF